Shire Human Genetic Therapies, Inc.'s Net Worth
Estimate Recalculated Sep 9, 2024 12:28AM EST
Who is Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. has an estimated net worth of $146 Million. This is based on reported shares in Translate Bio, Inc..
SEC CIK
Shire Human Genetic Therapies, Inc.'s CIK is 0001745009
Past Insider Trading and Trends
2018 was Shire Human Genetic Therapies, Inc.'s most active year for acquiring shares with 1 total transactions. Shire Human Genetic Therapies, Inc.'s most active month to acquire stocks was the month of June. 2020 was Shire Human Genetic Therapies, Inc.'s most active year for disposing of shares, totalling 6 transactions. Shire Human Genetic Therapies, Inc.'s most active month to dispose stocks was the month of May. 2018 saw Shire Human Genetic Therapies, Inc. paying a total of $0.00 for 183,619 shares, this is the most they've acquired in one year. In 2020 Shire Human Genetic Therapies, Inc. cashed out on 7,078,945 shares for a total of $146,169,557.13, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Translate Bio, Inc.
Form 4 | -100.00% | -6.82M | $20.68 | -$141.14M | Jun 30, 2020 | — | Sale | — | Jun 30 |
Form 4 | -0.58% | -40.09K | $19.75 | -$791.70K | Jun 05, 2020 | 6.82M | Sale | — | Jun 03 |
Form 4 | -3.02% | -213.87K | $19.81 | -$4.24M | Jun 03, 2020 | 6.87M | Sale | — | Jun 01 - Jun 02 |
Form 4 | 2.66% | 183.62K | — | — | Jul 02, 2018 | 7.08M | Acquisition | — | Jul 02 |
Form 3 | — | — | — | — | Jun 27, 2018 | 6.90M | — | — | — |
